Chlorine in PDB 8bl1: Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose

Enzymatic activity of Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose

All present enzymatic activity of Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose:
2.3.1.286;

Protein crystallography data

The structure of Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose, PDB code: 8bl1 was solved by W.You, C.Steegborn, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.84 / 2.06
Space group P 63
Cell size a, b, c (Å), α, β, γ (°) 91.688, 91.688, 144.35, 90, 90, 120
R / Rfree (%) 17.8 / 21.6

Other elements in 8bl1:

The structure of Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose also contains other interesting chemical elements:

Zinc (Zn) 2 atoms
Fluorine (F) 2 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose (pdb code 8bl1). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose, PDB code: 8bl1:
Jump to Chlorine binding site number: 1; 2; 3;

Chlorine binding site 1 out of 3 in 8bl1

Go back to Chlorine Binding Sites List in 8bl1
Chlorine binding site 1 out of 3 in the Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl409

b:66.2
occ:1.00
O2 A:PEG404 3.6 59.5 1.0
C3 A:PEG404 3.7 54.0 1.0
C2 A:PEG404 3.7 59.9 1.0
O12 A:QY3403 3.8 40.6 1.0
CE2 A:PHE86 3.8 26.1 1.0
CD2 A:PHE86 4.5 28.7 1.0
C1 A:PEG404 4.7 62.4 1.0
CZ A:PHE86 4.8 29.6 1.0
CE A:MET136 4.9 79.8 1.0
C4 A:PEG404 5.0 56.3 1.0

Chlorine binding site 2 out of 3 in 8bl1

Go back to Chlorine Binding Sites List in 8bl1
Chlorine binding site 2 out of 3 in the Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl410

b:54.2
occ:1.00
NE A:ARG103 3.4 57.3 1.0
CG A:ARG103 3.5 43.7 1.0
CB A:ARG103 3.8 39.7 1.0
CB A:LEU286 3.9 42.5 1.0
CG A:LEU289 3.9 29.9 1.0
CD A:ARG103 3.9 51.9 1.0
CD1 A:LEU289 3.9 30.8 1.0
CD1 A:LEU286 3.9 44.6 1.0
CD2 A:LEU289 4.2 28.6 1.0
O A:PRO287 4.4 39.1 1.0
CZ A:ARG103 4.4 61.4 1.0
CA A:ARG103 4.4 36.2 1.0
NH1 A:ARG103 4.4 70.9 1.0
CG A:LEU286 4.5 41.9 1.0
O A:ARG103 4.6 31.5 1.0
O A:HOH508 4.9 46.2 1.0
CA A:LEU286 5.0 40.1 1.0

Chlorine binding site 3 out of 3 in 8bl1

Go back to Chlorine Binding Sites List in 8bl1
Chlorine binding site 3 out of 3 in the Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 3 of Human SIRT6 in Complex with the Inhibitor S6039 and Adp-Ribose within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Cl409

b:57.1
occ:1.00
CD B:ARG103 3.1 53.7 1.0
CD1 B:LEU289 3.8 50.9 1.0
CG B:ARG103 3.8 45.1 1.0
CG B:LEU289 3.8 46.4 1.0
CD1 B:LEU286 3.8 66.5 1.0
NH1 B:ARG103 3.9 64.4 1.0
CB B:LEU286 3.9 55.7 1.0
CB B:ARG103 4.0 43.7 1.0
CD2 B:LEU289 4.1 43.8 1.0
NE B:ARG103 4.3 53.1 1.0
O B:PRO287 4.4 49.6 1.0
CG B:LEU286 4.5 61.2 1.0
CZ B:ARG103 4.5 59.0 1.0
CA B:ARG103 4.7 39.5 1.0
O B:ARG103 4.9 42.9 1.0

Reference:

W.You, C.Steegborn. Development of Novel Sirtuin 6 Inhibitors and Activators Based on A Protein Crystallography-Based Fragment Screen To Be Published.
Page generated: Tue Jul 30 07:18:12 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy